MedPath

Analgesic effect of Xeomin injection in the scalp on pain intensity in patients with chronic migraine

Phase 2
Conditions
Chronic migraine.
Migraine
Registration Number
IRCT20200217046523N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Having chronic migraine
Complaints of headache despite treatment for six months of migraine prophylaxis with antiepileptics, TCAs and beta-blockers
Having informed consent of patients to participate in the study

Exclusion Criteria

Pregnancy and lactation
Having any underlying disease
Taking anticoagulants

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of pain. Timepoint: Before and one month and two months and three months after the intervention. Method of measurement: By Visual Analogue Scale questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath